How life sciences can partner with health system leaders to improve patient outcomes
Most of the U.S. healthcare market is served by large health systems with ever-expanding priorities and challenges—including rising labor costs, inflation, falling reimbursement and staffing shortages. In this environment, where gaps are widening between what healthcare consumers in the U.S. expect and what their doctors and hospitals provide, leaders across the ecosystem need to form partnerships to improve patient care.
A new ZS study asked health system leaders what they see as their priorities and challenges for 2023 and how they’d want to partner with life sciences companies to improve patient outcomes.
During this webinar, we share the results of our study and examine:
- How the findings affect the life sciences industry
- The importance of developing a sophisticated B2B engagement capability
- How partnerships can offer a win for patients, a win for health systems and a win for life sciences manufacturers
Related insights
zs:topic/strategy-&-advisory,zs:topic/technology-&-operations,zs:topic/marketing,zs:topic/sales,zs:topic/value-&-access,zs:topic/sales-compensation,zs:topic/supply-chain-and-manufacturing,zs:
